82 articles
HRAS
HRAS (Harvey rat sarcoma viral oncogene homolog), a proto-oncogene on 11p15.5, was the first human oncogene cloned (1982, T24 bladder carcinoma). Germline activating mutations cause Costello syndrome; somatic HRAS mutations are rare in cancer.
ING1
ING1 (inhibitor of growth family member 1, p33ING1) is a human tumor suppressor gene on 13q34 encoding nuclear PHD-finger proteins that bind H3K4me3, recruit Sin3A/HDAC complexes, cooperate with p53, and are frequently downregulated in cancers.
MACC1
MACC1 (Metastasis Associated in Colon Cancer 1), gene at 7p21.1 regulating HGF/MET signaling; prognostic biomarker for metastasis and poor survival in over 20 solid cancers.
MAGEA3
MAGEA3 (melanoma-associated antigen 3, MAGE-A3) is a human Xq28 cancer-testis antigen gene expressed in testis, placenta, and many tumors. It activates TRIM28-mediated ubiquitination of p53 and AMPK; its phase III vaccine trials (MAGRIT, DERMA) failed, and MAGE-A3 TCR therapy caused fatal titin and MAGE-A12 cross-reactive toxicity.
MAP3K8
MAP3K8, also called TPL2 or COT (cancer Osaka thyroid), is a human oncogene on 10p11.23 encoding a serine/threonine MAP kinase kinase kinase that activates ERK/JNK and NF-kappaB signaling in inflammation and cancer.
MCL1
MCL1 (myeloid cell leukemia-1) is an antiapoptotic BCL2 family protein with a 1-3 hour half-life, essential for hematopoietic and neutrophil survival, overexpressed in cancer, and targeted by BH3-groove inhibitors such as AMG 176, AZD5991, and S64315, limited by cardiotoxicity.
MDM4
MDM4 (MDMX, HDMX), gene ID 4194 at 1q32, encodes a 490-aa p53 negative regulator that heterodimerizes with MDM2 to drive p53 ubiquitination and has p53-independent roles in DNA repair and replication; overexpressed in about 20% of cancers.
MEN1
MEN1 (menin 1) is a tumor suppressor gene on chromosome 11q13; germline mutations cause multiple endocrine neoplasia type 1, a syndrome of parathyroid, pancreatic endocrine, and pituitary tumors. Menin also acts as an oncogenic KMT2A co-factor in AML.
Menin
Menin, the 610 amino acid protein encoded by the MEN1 gene at 11q13, is a nuclear tumor-suppressor scaffold in MLL1/2 H3K4 methyltransferase complexes; its loss causes MEN1 syndrome and its inhibition treats KMT2A-rearranged AML.
MET
MET, also known as c-Met or HGFR, is a human proto-oncogene on chromosome 7 that encodes the hepatocyte growth factor receptor; its dysregulation contributes to cancer progression and metastasis.
Migration and invasion-inhibitory protein
MIIP (IIP45), a 43 kDa tumor-suppressor protein encoded at human chromosome 1p36.22, inhibits cell migration and invasion by binding HDAC6, IGFBP2, Cdc20, and ITGB3; its loss or deletion promotes metastasis in several cancers.
MSI2
MSI2 (musashi RNA binding protein 2, MUSASHI2) is a chromosome 17q22 gene encoding a two-RRM RNA-binding protein that maintains hematopoietic stem cell self-renewal, acts as an oncogene in AML and other cancers, and carries a protective clonal hematopoiesis variant.
MTDH
MTDH (metadherin), also called AEG-1 or LYRIC, is a human chromosome 8q22.1 gene encoding a 582-amino-acid transmembrane oncoprotein, discovered in 2002 in HIV-1-infected astrocytes and overexpressed across many cancers.
NDRG1
NDRG1 (N-myc downstream-regulated gene 1, Cap43, RTP), chromosome 8q24.22, encodes a 394-aa stress-response protein; tumor suppressor or promoter depending on cancer type, and mutated in Charcot-Marie-Tooth disease type 4D.
NDRG2
NDRG2 (NDRG family member 2, SYLD), a protein-coding gene at 14q11.2 encoding a 371-aa nonenzymatic alpha/beta hydrolase expressed in astrocytes; a candidate tumor suppressor downregulated via promoter methylation in many cancers.
NF2
NF2 (neurofibromatosis type 2 gene, also merlin or schwannomin) is a tumor suppressor gene at 22q12.2 encoding the FERM-domain protein merlin; germline loss causes NF2-related schwannomatosis with bilateral vestibular schwannomas, and somatic NF2 loss drives meningioma and mesothelioma.
NME1
NME1 (NM23-H1, NDPK-A) is the human gene encoding nucleoside diphosphate kinase A; discovered in 1988 as the first metastasis suppressor gene, it suppresses metastasis without blocking primary tumor growth.
NUP214
NUP214 (nucleoporin 214, formerly CAN), human gene at 9q34.13 encoding an FG-repeat nuclear pore protein on the pore's cytoplasmic face; rearranged in leukemia (DEK-NUP214, SET-NUP214, NUP214-ABL1) and mutated in acute febrile encephalopathy.
NUP98
NUP98, formally the NUP98 and NUP96 precursor gene, is a human gene on chromosome 11p15 encoding nuclear pore proteins Nup98 and Nup96, and a frequent leukemia fusion gene.
NUTM1
NUTM1, also known as NUT or C15orf55, is a human gene on chromosome 15, normally active in testicular germ cells, whose rearrangement with BRD4 drives aggressive NUT carcinoma.
PAWR
PAWR (Par-4, prostate apoptosis response-4) is a human chromosome 12q21 gene encoding a tumor suppressor that selectively induces apoptosis in cancer cells via PKA-phosphorylated, nuclear Fas/NF-κB signaling and secreted GRP78-binding mechanisms.
PDCD4
PDCD4 (programmed cell death 4, H731), a tumor suppressor gene on human chromosome 10 (10q25.2), encodes a 469-aa protein that binds eIF4A via two MA3 domains, blocks translation initiation, and whose loss predicts poor cancer survival.
PIK3CA
PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) encodes p110α of PI3Kα on chromosome 3; hotspot-mutated in over 30% of breast cancers, a biomarker for PI3K/AKT inhibitor therapy, and causative of PROS overgrowth disorders.
PIM1
PIM1 (Pim-1 proto-oncogene, HGNC:8986, 6p21.2) encodes a serine/threonine kinase of the PIM family, discovered in 1984 as a retroviral insertion site in mouse lymphomas; JAK/STAT-regulated, overexpressed in hematologic malignancies and prostate cancer, with no approved inhibitor.
PLAG1
PLAG1 (pleomorphic adenoma gene 1), a proto-oncogene at human chromosome 8q12, encodes a zinc finger transcription factor activated by promoter-swapping fusions in salivary gland pleomorphic adenoma and lipoblastoma, and is a major stature locus in cattle.
PMAIP1
PMAIP1, also called NOXA or APR, is a human gene on 18q21.32 encoding a 54-aa BH3-only pro-apoptotic BCL-2 family protein induced by p53 and other stress factors; it binds MCL1 and is a cancer prognostic biomarker.
POT1
POT1 (protection of telomeres 1), HGNC:17284, is a human shelterin gene binding telomeric TTAGGG single-stranded DNA. Germline pathogenic variants cause POT1 tumor predisposition syndrome: melanoma, angiosarcoma, CLL, glioma.
PRAME
PRAME, or Preferentially Expressed Antigen in Melanoma, is a human cancer-testis antigen discovered in 1997, expressed in melanoma and leukemia and a target of immunotherapies in Phase 3 trials.
PRKCI
PRKCI (protein kinase C iota, PKCι; mouse homolog PKCλ) is a human gene at 3q26.2 encoding an atypical PKC serine/threonine kinase, a bona fide oncogene amplified in cervical, head and neck, lung squamous, and ovarian cancers.
Prostate apoptosis response 4
Prostate apoptosis response 4 (Par-4) is a pro-apoptotic tumor suppressor protein, first identified in 1994 in a rat prostate cancer cell line, that kills cancer cells selectively.